Neurocore Uses Neurofeedback to Treat ADHD

To this day, ADHD remains one of the most prevalent neurological disorders among people aged eighteen and under which has made it paramount for multiple scientists and research organizations to study it and develop the most effective treatment methods possible. One of the most prominent organizations developing treatment methods for ADHD is known as Neurocore. Back in 1976, J.F. Lubar was one of the very first scientists researching this disorder and he made significant headway in his research. Now, Neurocore is using his findings in conjunction with modern technology to develop the most effective methods of treating patients with ADHD. The organization has already made significant progress with over three-fourths of their patients reporting a significant reduction in the severity of symptoms and over half of them no longer meeting the qualifications necessary to be classified as a patient with ADHD.

Using modern technology known as Qeeg, they’ve been able to analyze the brainwaves of patients to try and determine the root cause of the disorder. So far, they’ve been able to determine that an excess amount of theta waves can be a telling sign of ADHD as well as a significant downturn in the number of beta waves in patients. Additionally, they determined that this particular disorder can be divided into three separate subcategories. The first one is characterized by symptoms of inattentiveness and the second one is characterized by a lack of impulse control and the inability to sit still. The last one is merely the first two subcategories combined.

ADHD is notorious for lasting well into adulthood which makes it imperative for scientists to continue their research and develop the most effective treatment methods possible. Many of the symptoms of ADHD can often be caused by vision impairment, sleep disorders, anxiety, and many other conditions. They’ve also done recent studies that have determined that the disorder can often be a hereditary trait passed down from one generation to the next. So we wish them the best of luck in the future of their research and hope they are successful in someday finding a cure for this disorder.